On the cutting edge of obstructive sleep apnoea: where next?
Atul Malhotra, Jeremy E Orr, Robert L Owens, Atul Malhotra, Jeremy E Orr, Robert L Owens
Abstract
Obstructive sleep apnoea is a common disease that is now more widely recognised because of the rise in prevalence and the increasingly compelling data that shows major neurocognitive and cardiovascular sequelae. At the same time, the clinical practice of sleep medicine is changing rapidly, with novel diagnostics and treatments that have established a home-based (rather than laboratory-based) management approach. We review the most recent insights and discoveries in obstructive sleep apnoea, with a focus on diagnostics and therapeutics. As will be discussed, management of obstructive sleep apnoea could soon transition from a so-called one size fits all approach to an individualised approach.
Conflict of interest statement
Declaration of interests
AM and JEO declare no competing interests. RLO reports personal fees from Philips Respironics, outside of the submitted work.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Figures
Source: PubMed